TABLE 3: Survival rates on day 28.

	Survival on day 28
	Survival		Mortality
	N	%	N	%	Total	Relative risk (CI 95%)
Ixekizumab	13	81.3	3	18.8	16	1.50 (0.29-7.81)
Low-dose IL-2	11	78.6	3	21.4	14	1.71 (0.33-8.83)
Colchicine	14	100.0	0	0.0	14	-
SOC	14	87.5	2	12.5	16	1
Total	52	86.7	8	13.3	60

SOC: Standard of care; IL-2: interleukin 2; p-value Fisher's exact test: 0.340; CI: confidence interval.